Atovaquone/Proguanil Enfants Biogaran

Atovaquone/Proguanil Enfants Biogaran is a combination medication used for malaria prevention and treatment. This oral medication is suitable for children and is manufactured by Laboratoire Glaxosmithkline.

Atovaquone/Proguanil Enfants Biogaran is primarily used for the prevention and treatment of malaria, a mosquito-borne disease. It is often prescribed for travelers to areas where malaria is common. The medication works by interfering with the growth of parasites that cause malaria, helping to reduce the risk of infection or alleviate symptoms.

Common effects of Atovaquone/Proguanil Enfants Biogaran may include stomach pain, nausea, vomiting, diarrhea, headache, and cough. Some users might also experience loss of appetite or dizziness. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare professional.

Atovaquone/Proguanil Enfants Biogaran should be used with caution in individuals with severe kidney disease or metabolic disorders. It is important to follow the prescribed dosage and complete the full course of treatment. Store the medication in a cool, dry place away from direct sunlight and keep it out of reach of children.

Atovaquone/Proguanil Enfants Biogaran may interact with certain medications, including antacids, metoclopramide, and drugs that affect liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol should be avoided as it may increase the risk of side effects.